Dr. D'Amato is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Sylvester Comprehensive Cancer Center/University of Miami Health System
1120 NW 14th St Suite 610
Miami, FL 33136Phone+1 305-243-2581Fax+1 305-243-9161
Education & Training
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2001 - 2004
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1998 - 2001
University of Miami Leonard M. Miller School of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2003 - 2027
GA State Medical License 2008 - 2019
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Atlanta Magazine: Top Doctors Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
Clinical Trials
- Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma Start of enrollment: 2007 Mar 01
- Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
- Phase 3 Study to Treat Patients With Soft Tissue Sarcomas Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 18 citationsClinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study.John Zalcberg, Michael Heinrich, Suzanne George, Sebastian Bauer, Patrick Schöffski
The Oncologist. 2021-11-01 - 36 citationsGenomic Landscape of Angiosarcoma: A Targeted and Immunotherapy Biomarker Analysis.Andrea P. Espejo-Freire, Andrew Elliott, Andrew E. Rosenberg, Philippos Apolinario Costa, Priscila Barreto-Coelho
Cancers. 2021-09-26 - 23 citationsClinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study.Sebastian Bauer, Michael Heinrich, Suzanne George, John Zalcberg, César Serrano
Clinical Cancer Research. 2021-09-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
